Robinson S. Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and/or BCL-2 Inhibitor Failure. Can Hematol Today [Internet]. 2024 Jun. 27 [cited 2024 Sep. 16];3(2):49–53. Available from: https://canadianhematologytoday.com/article/view/3-2-robinson